5 EASY FACTS ABOUT IS ABBV-744 EFFECTIVE FOR HEMATOLOGIC CANCERS? DESCRIBED

In Phase C, individuals will receive ABBV-744 and oral navitoclax. In Section D, contributors will obtain ABBV-744 and ruxolitinib. Members will receive treatment till sickness progression or the members are unable to tolerate the study drugs.- Participant eaten grapefruit or grapefruit merchandise within 3 times just before the initial dose of stu